Omer Ad
Impact in
- Structural Biology top 10%
-
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Chemical Synthesis and Analysis
- Genomics and Phylogenetic Studies
- RNA Research and Splicing
Papers in
-
- RNA and protein synthesis mechanisms 7
- Chemical Synthesis and Analysis 3
- RNA modifications and cancer 3
- Glycosylation and Glycoproteins Research 2
- Enzyme Catalysis and Immobilization 2
- Co-authors
- Alanna Schepartz (8 shared papers)J.H.D. Cate (4 shared papers)Fred R. Ward (4 shared papers)Zoe L. Watson (2 shared papers)Raphaël Méheust (1 shared paper)Jillian F. Banfield (1 shared paper)Joyce Liu (2 shared papers)Wenjun Zhang (2 shared papers)
- Journals
- ACS Central Science (3 papers)Proceedings of the National Academy of Sciences (2 papers)Biochemistry (2 papers)Angewandte Chemie International Edition (2 papers)Chemical Research in Toxicology (1 paper)
- Partner nations
- United States
In The Last Decade
Omer Ad
15 papers receiving 571 citations
Peers
Comparison fields: 5 of 70
- Structural Biology 14
- Molecular Biology 460
- Pharmacology 69
- Pharmaceutical Science 21
- Genetics 89
Countries citing papers authored by Omer Ad
This map shows the geographic impact of Omer Ad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omer Ad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omer Ad more than expected).
Fields of papers citing papers by Omer Ad
This network shows the impact of papers produced by Omer Ad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omer Ad. The network helps show where Omer Ad may publish in the future.
Co-authors
The 25 scholars most cited alongside Omer Ad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 175 | |
| 2 | 2013 | 62 | |
| 3 | 2016 | 61 | |
| 4 | 2019 | 56 | |
| 5 | 2022 | 45 | |
| 6 | 2019 | 42 | |
| 7 | 2023 | 32 | |
| 8 | 2017 | 22 | |
| 9 | 2021 | 19 | |
| 10 | 2014 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2014 | 13 | |
| 13 | 2013 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 3 | |
| 16 | Hybrid promiscuous (Hypr) GGDEF enzymes produce cyclic AMP-GMP (3 ', 3 '-cGAMP) | 2016 | 0 |
| 17 | 2026 | 0 |
About Omer Ad
Omer Ad is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Genetics and Pharmacology, having authored 17 papers that have together received 574 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (7 papers), Peptidase Inhibition and Analysis (3 papers), Bacterial Genetics and Biotechnology (3 papers), Chemical Synthesis and Analysis (3 papers), RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (2 papers), Enzyme Catalysis and Immobilization (2 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Structural Biology (14 citations), Molecular Biology (460 citations), Pharmacology (69 citations), Pharmaceutical Science (21 citations) and Genetics (89 citations). Omer Ad has collaborated with scholars based in United States. Frequent co-authors include Alanna Schepartz, J.H.D. Cate, Fred R. Ward, Zoe L. Watson, Raphaël Méheust, Jillian F. Banfield, Joyce Liu, Wenjun Zhang, Zhe Rui and Dieter Söll. Their work appears in journals such as ACS Central Science, Proceedings of the National Academy of Sciences, Biochemistry, Angewandte Chemie International Edition and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.